Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XVII.c

Aspergillosis, pulmonary (invasive, allergic [ABPA], or mycetoma)

Publications

Kurosaki F, Bando M, Nakayama M, Mato N, Nakaya T, Yamasawa H, Yoshimoto T, Fukushima N, Sugiyama Y

Clinical features of pulmonary aspergillosis associated with interstitial pneumonia.

Internal medicine (Tokyo, Japan). 2014;53(12):1299-306

Montagna MT, Lovero G, Coretti C, Martinelli D, Delia M, De Giglio O, Caira M, Puntillo F, D'Antonio D, Venditti M, Sambri V, Di Bernardo F, Barbui A, Lo Cascio G, Concia E, Mikulska M, Viscoli C, Maximova N, Candoni A, Oliveri S, Lombardi G, Pitzurra L,

SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients.

Infection. 2014;42(1):141-51

Wessolossky M, Welch VL, Sen A, Babu TM, Luke DR

Invasive Aspergillus infections in hospitalized patients with chronic lung disease.

Infection and drug resistance. 2013;6:33-9

Tunnicliffe G, Schomberg L, Walsh S, Tinwell B, Harrison T, Chua F

Airway and parenchymal manifestations of pulmonary aspergillosis.

Respiratory medicine. 2013;107(8):1113-23

Choi YR, Kim JT, Kim JE, Jung HW, Choe KH, Lee KM, An JY

Invasive aspergillosis involving the lungs and brain after short period of steroid injection: a case report.

Tuberculosis and respiratory diseases. 2012;72(5):448-51

Fernández-Ruiz M, Silva JT, San-Juan R, de Dios B, García-Luján R, López-Medrano F, Lizasoain M, Aguado JM

Aspergillus tracheobronchitis: report of 8 cases and review of the literature.

Medicine. 2012;91(5):261-273

Papadopoulos A, Ntaios G, Kaiafa G, Girtovitis F, Charisopoulos G, Chryssogonidis I

Fatal pulmonary and cerebral aspergillosis after a short course of corticosteroids for idiopathic thrombocytopenic purpura.

Annals of hematology. 2008;87(8):685-6

Chong S, Lee KS, Yi CA, Chung MJ, Kim TS, Han J

Pulmonary fungal infection: imaging findings in immunocompetent and immunocompromised patients.

European journal of radiology. 2006;59(3):371-83

Cornet M, Mallat H, Somme D, Guérot E, Kac G, Mainardi JL, Fornes P, Gutmann L, Lavarde V

Fulminant invasive pulmonary aspergillosis in immunocompetent patients--a two-case report.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2003;9(12):1224-7

Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1998;26(6):1473-5

Palmer LB, Greenberg HE, Schiff MJ

Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease.

Thorax. 1991;46(1):15-20